|
|
Volumn 130, Issue 2, 2008, Pages 66-70
|
|
New therapeutic options in protracted hiv-infected patients with virological failure;Nuevas perspectivas en el del paciente con infección por el virus de la inmunodeficiencia humana politratado y en fracaso virológico
a
|
|
Author keywords
Darunavir; Enfuvirtide; HIV; Raltegravir; Tipranavir; Virological failure
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
DARUNAVIR;
ELVITEGRAVIR;
ENFUVIRTIDE;
ETRAVIRINE;
MARAVIROC;
PROTEINASE INHIBITOR;
RALTEGRAVIR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TIPRANAVIR;
VIRUS RNA;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TREATMENT FAILURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERAMYLASEMIA;
HYPERLIPIDEMIA;
LEUKOPENIA;
LIVER TOXICITY;
NONHUMAN;
PRACTICE GUIDELINE;
RASH;
REVIEW;
STEVENS JOHNSON SYNDROME;
TREATMENT OUTCOME;
|
|
EID: 39749085973
PISSN: 00257753
EISSN: 15788989
Source Type: Journal
DOI: 10.1157/13115036 Document Type: Review |
|
Times cited : (2)
|
|
References (21)
|
